Private Advisor Group, LLC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 1 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Private Advisor Group, LLC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$7,000
+133.3%
14,000
+250.0%
0.00%
Q2 2020$3,000
-95.5%
4,000
-90.8%
0.00%
-100.0%
Q4 2019$67,000
-15.2%
43,4000.0%0.00%0.0%
Q3 2019$79,000
+21.5%
43,400
+10.2%
0.00%0.0%
Q2 2019$65,000
+8.3%
39,400
+17.6%
0.00%0.0%
Q1 2019$60,000
-55.2%
33,500
-10.7%
0.00%
-66.7%
Q3 2018$134,00037,5000.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$21,793,00011.58%
Kore Private Wealth LLC 202,366$105,0000.02%
BARD ASSOCIATES INC 335,750$175,0000.02%
HighTower Advisors, LLC 5,284,688$2,738,0000.01%
GSA CAPITAL PARTNERS LLP 126,529$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 654,200$339,0000.01%
Virtu Financial LLC 57,076$30,0000.01%
WEDBUSH SECURITIES INC 81,500$42,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 33,933$18,0000.00%
MATRIX ASSET ADVISORS INC/NY 39,500$20,0000.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders